Jazz Pharmaceuticals , Nasdaq: JAZZ
Developing treatments for various neurological and psychiatric disorders.
Industry: Health Care
First Day Return: -1.5%
Industry: Health Care
JAZZ
Developing treatments for various neurological and psychiatric disorders.
| IPO Data | |
|---|---|
| IPO File Date | 03/09/2007 |
| Offer Price | $18.00 |
| Price Range $24.00 - $26.00 | |
| Offer Shares (mm) | 6.0 |
| Deal Size ($mm) | $108 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 05/31/2007 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $108 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Palo Alto, CA, United States |
| Founded | 2003 |
| Employees at IPO | 407 |
| Website www.jazzpharmaceuticals.com | |
IPO News for Jazz Pharmaceuticals
Jazz Pharmaceuticals (JAZZ) Performance
